COVID-19-associated fungal infections
Abstract Coronavirus disease 2019 (COVID-19)-associated invasive fungal infections are an
important complication in a substantial number of critically ill, hospitalized patients with …
important complication in a substantial number of critically ill, hospitalized patients with …
Tackling the emerging threat of antifungal resistance to human health
Invasive fungal infections pose an important threat to public health and are an under-
recognized component of antimicrobial resistance, an emerging crisis worldwide. Across a …
recognized component of antimicrobial resistance, an emerging crisis worldwide. Across a …
A visual and comprehensive review on COVID-19-associated pulmonary aspergillosis (CAPA)
Coronavirus disease 19 (COVID-19)-associated pulmonary aspergillosis (CAPA) is a severe
fungal infection complicating critically ill COVID-19 patients. Numerous retrospective and …
fungal infection complicating critically ill COVID-19 patients. Numerous retrospective and …
Lung epithelial and myeloid innate immunity in influenza-associated or COVID-19-associated pulmonary aspergillosis: an observational study
S Feys, SM Gonçalves, M Khan, S Choi… - The Lancet …, 2022 - thelancet.com
Background Influenza-associated pulmonary aspergillosis (IAPA) and COVID-19-associated
pulmonary aspergillosis (CAPA) affect about 15% of critically ill patients with influenza or …
pulmonary aspergillosis (CAPA) affect about 15% of critically ill patients with influenza or …
A B1a–natural IgG–neutrophil axis is impaired in viral-and steroid-associated aspergillosis
The lung naturally resists Aspergillus fumigatus (Af) in healthy individuals, but multiple
conditions can disrupt this resistance, leading to lethal invasive infections. Core processes …
conditions can disrupt this resistance, leading to lethal invasive infections. Core processes …
Increased deaths from fungal infections during the coronavirus disease 2019 pandemic—National Vital Statistics System, United States, January 2020–December …
Abstract Background Coronavirus disease 2019 (COVID-19)–associated fungal infections
cause severe illness, but comprehensive data on disease burden are lacking. We analyzed …
cause severe illness, but comprehensive data on disease burden are lacking. We analyzed …
Invasive pulmonary aspergillosis among intubated patients with SARS-CoV-2 or influenza pneumonia: a European multicenter comparative cohort study
A Rouzé, E Lemaitre, I Martin-Loeches, P Povoa… - Critical Care, 2022 - Springer
Background Recent multicenter studies identified COVID-19 as a risk factor for invasive
pulmonary aspergillosis (IPA). However, no large multicenter study has compared the …
pulmonary aspergillosis (IPA). However, no large multicenter study has compared the …
Corticosteroids as risk factor for COVID-19-associated pulmonary aspergillosis in intensive care patients
R Leistner, L Schroeter, T Adam, D Poddubnyy… - Critical Care, 2022 - Springer
Purpose Corticosteroids, in particular dexamethasone, are one of the primary treatment
options for critically ill COVID-19 patients. However, there are a growing number of cases …
options for critically ill COVID-19 patients. However, there are a growing number of cases …
High burden of COVID-19-associated pulmonary aspergillosis in severely immunocompromised patients requiring mechanical ventilation
Abstract Background Coronavirus disease 2019 (COVID-19)–associated pulmonary
aspergillosis (CAPA) is a frequent superinfection in critically ill patients with COVID-19 and …
aspergillosis (CAPA) is a frequent superinfection in critically ill patients with COVID-19 and …
Prevalence of COVID-19-associated pulmonary aspergillosis: critical review and conclusions
First reports of cases and case series of COVID-19-associated pulmonary aspergillosis
(CAPA) emerged during the first months of the pandemic. Prevalence rates varied widely …
(CAPA) emerged during the first months of the pandemic. Prevalence rates varied widely …